SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal - Quaterly Results

14 May 2025 Evaluate
A fair growth of 7.45% in the revenue at Rs. 5524.00 millions was reported in the March 2025 quarter as compared to Rs. 5141.00 millions during year-ago period.A good growth in profit of 48.82% reported to Rs. 503.00  millions over Rs. 338.00 millions of corresponding previous quarter.Operating profit for the quarter ended March 2025 rose to 1240.00 millions as compared to 948.00 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5524.00 5141.00 7.45 18598.00 17846.00 4.21 18598.00 17846.00 4.21
Other Income 5.00 5.00 0.00 50.00 25.00 100.00 50.00 25.00 100.00
PBIDT 1240.00 948.00 30.80 3335.00 2694.00 23.79 3335.00 2694.00 23.79
Interest 179.00 153.00 16.99 752.00 564.00 33.33 752.00 564.00 33.33
PBDT 1061.00 795.00 33.46 2583.00 2130.00 21.27 2583.00 2130.00 21.27
Depreciation 377.00 323.00 16.72 1344.00 1176.00 14.29 1344.00 1176.00 14.29
PBT 684.00 472.00 44.92 1239.00 954.00 29.87 1239.00 954.00 29.87
TAX 181.00 134.00 35.07 330.00 259.00 27.41 330.00 259.00 27.41
Deferred Tax 8.00 -26.00 -130.77 30.00 -25.00 -220.00 30.00 -25.00 -220.00
PAT 503.00 338.00 48.82 909.00 695.00 30.79 909.00 695.00 30.79
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 22.45 18.44 21.73 17.93 15.10 18.79 17.93 15.10 18.79

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×